| Results summary | View all lists in GO:BiolProc | View all genes in C01A.profile.ud50 |
regulation of cellular process Any process that modulates the frequency, rate or extent of cellular processes, those that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level. enrichment: 1.60-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 208003_S_AT | NFAT5 | R | S | nuclear factor of activated T-cells 5, tonicity-responsive | |||||||||
| 218229_S_AT | POGK | G | D | R | pogo transposable element with KRAB domain | ||||||||
| 219169_S_AT | TFB1M | R | transcription factor B1, mitochondrial | ||||||||||
| 37028_AT | PPP1R15A | G | X | protein phosphatase 1, regulatory (inhibitor) subunit 15A | |||||||||
| 218192_AT | IHPK2 | G | inositol hexaphosphate kinase 2 | ||||||||||
| 213359_AT | HNRPD | R | heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) | ||||||||||
| 201473_AT | JUNB | R | jun B proto-oncogene | ||||||||||
| 218880_AT | FOSL2 | R | FOS-like antigen 2 | ||||||||||
| 207826_S_AT | ID3 | D | R | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | |||||||||
| 36711_AT | MAFF | D | R | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | |||||||||
| 209219_AT | RDBP | R | RD RNA binding protein | ||||||||||
| 216248_S_AT | NR4A2 | D | R | C | S | nuclear receptor subfamily 4, group A, member 2 | |||||||
| 206036_S_AT | REL | P | R | S | v-rel reticuloendotheliosis viral oncogene homolog (avian) | ||||||||
| 221496_S_AT | TOB2 | G | transducer of ERBB2, 2 | ||||||||||
| 201694_S_AT | EGR1 | D | R | early growth response 1 | |||||||||
| 214016_S_AT | SFPQ | X | R | splicing factor proline/glutamine-rich (polypyrimidine tract binding protein associated) | |||||||||
| 218987_AT | ATF7IP | R | activating transcription factor 7 interacting protein | ||||||||||
| 201693_S_AT | EGR1 | D | R | early growth response 1 | |||||||||
| 214638_S_AT | CCNT2 | R | cyclin T2 | ||||||||||
| 218647_S_AT | YRDC | T | yrdC domain containing (E. coli) | ||||||||||
| 209189_AT | FOS | D | X | R | v-fos FBJ murine osteosarcoma viral oncogene homolog | ||||||||
| 204159_AT | CDKN2C | G | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | ||||||||||
| 221890_AT | ZNF335 | R | zinc finger protein 335 | ||||||||||
| 203958_S_AT | ZBTB40 | R | zinc finger and BTB domain containing 40 | ||||||||||
| 206734_AT | JRKL | D | R | jerky homolog-like (mouse) | |||||||||
| 213269_AT | ZNF248 | R | zinc finger protein 248 | ||||||||||
| 220046_S_AT | CCNL1 | R | cyclin L1 | ||||||||||
| 204621_S_AT | NR4A2 | D | R | C | S | nuclear receptor subfamily 4, group A, member 2 | |||||||
| 200797_S_AT | MCL1 | G | D | S | myeloid cell leukemia sequence 1 (BCL2-related) | ||||||||
| 204622_X_AT | NR4A2 | D | R | C | S | nuclear receptor subfamily 4, group A, member 2 | |||||||
| 202535_AT | FADD | G | S | Fas (TNFRSF6)-associated via death domain | |||||||||
| 215092_S_AT | NFAT5 | R | S | nuclear factor of activated T-cells 5, tonicity-responsive | |||||||||
| 204094_S_AT | TSC22D2 | R | TSC22 domain family, member 2 | ||||||||||
| 218534_S_AT | AGGF1 | G | D | R | C | angiogenic factor with G patch and FHA domains 1 | |||||||
| 206789_S_AT | POU2F1 | R | POU domain, class 2, transcription factor 1 | ||||||||||
| 202014_AT | PPP1R15A | G | X | protein phosphatase 1, regulatory (inhibitor) subunit 15A | |||||||||
| 213913_S_AT | KIAA0984 | S | KIAA0984 protein | ||||||||||
| 218492_S_AT | THAP7 | R | THAP domain containing 7 | ||||||||||
| 208042_AT | AGGF1 | G | D | R | C | angiogenic factor with G patch and FHA domains 1 | |||||||
| 208961_S_AT | KLF6 | D | R | S | Kruppel-like factor 6 | ||||||||
| 212118_AT | TRIM27 | G | R | tripartite motif-containing 27 | |||||||||